William T. Dauer

14.2k total citations · 3 hit papers
91 papers, 10.6k citations indexed

About

William T. Dauer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, William T. Dauer has authored 91 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Neurology, 48 papers in Cellular and Molecular Neuroscience and 37 papers in Molecular Biology. Recurrent topics in William T. Dauer's work include Neurological disorders and treatments (36 papers), Parkinson's Disease Mechanisms and Treatments (32 papers) and Genetic Neurodegenerative Diseases (29 papers). William T. Dauer is often cited by papers focused on Neurological disorders and treatments (36 papers), Parkinson's Disease Mechanisms and Treatments (32 papers) and Genetic Neurodegenerative Diseases (29 papers). William T. Dauer collaborates with scholars based in United States, Greece and United Kingdom. William T. Dauer's co-authors include Serge Przedborski, Rose E. Goodchild, Howard J. Worman, David Sulzer, Lauren M. Tanabe, Hardy J. Rideout, Ana María Cuervo, Chun-Chi Liang, Lauren R. Kett and René Hen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

William T. Dauer

90 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkinson's Disease

2003 4.3k citations William T. Dauer, Serge Przedborski profile →
Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

2008 516 citations Marta Martínez‐Vicente, Zsolt Tallóczy et al. Journal of Clinical Investigation profile →
Interplay of LRRK2 with chaperone-mediated autophagy

2013 484 citations William T. Dauer, David Sulzer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William T. Dauer United States	39	6.2k	4.5k	3.5k	1.6k	1.3k	91	10.6k
Asa Abeliovich United States	30	3.4k 0.6×	3.6k 0.8×	4.1k 1.2×	1.6k 1.0×	1.1k 0.9×	46	8.4k
Lorraine V. Kalia Canada	33	4.4k 0.7×	3.3k 0.7×	3.0k 0.8×	1.6k 1.0×	610 0.5×	87	8.9k
Richard Wade‐Martins United Kingdom	55	4.6k 0.7×	3.1k 0.7×	4.4k 1.3×	2.5k 1.6×	908 0.7×	161	10.5k
Beisha Tang China	52	3.9k 0.6×	3.7k 0.8×	5.1k 1.5×	1.8k 1.1×	797 0.6×	548	10.9k
M. Maral Mouradian United States	62	6.5k 1.0×	5.5k 1.2×	5.6k 1.6×	1.8k 1.1×	673 0.5×	199	14.1k
Pamela J. McLean United States	55	6.4k 1.0×	3.7k 0.8×	4.3k 1.2×	4.3k 2.7×	2.2k 1.7×	112	12.0k
Darren J. Moore United States	49	6.8k 1.1×	2.8k 0.6×	4.5k 1.3×	2.6k 1.7×	1.7k 1.3×	86	10.2k
Günter U. Höglinger Germany	55	5.2k 0.8×	3.1k 0.7×	3.0k 0.9×	2.2k 1.4×	501 0.4×	284	10.8k
Veerle Baekelandt Belgium	58	4.7k 0.8×	3.4k 0.8×	5.3k 1.5×	2.7k 1.7×	1.1k 0.9×	218	11.7k
Bernard L. Schneider Switzerland	54	2.9k 0.5×	3.2k 0.7×	3.5k 1.0×	1.7k 1.1×	1.2k 0.9×	150	8.9k

Countries citing papers authored by William T. Dauer

Since Specialization

Citations

This map shows the geographic impact of William T. Dauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William T. Dauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William T. Dauer more than expected).

Fields of papers citing papers by William T. Dauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William T. Dauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William T. Dauer. The network helps show where William T. Dauer may publish in the future.

Co-authorship network of co-authors of William T. Dauer

This figure shows the co-authorship network connecting the top 25 collaborators of William T. Dauer. A scholar is included among the top collaborators of William T. Dauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William T. Dauer. William T. Dauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phan, Sébastien, Thomas R. Shaw, Sarah H. Shahmoradian, et al.. (2024). TorsinA is essential for neuronal nuclear pore complex localization and maturation. Nature Cell Biology. 26(9). 1482–1495. 6 indexed citations

Yellajoshyula, Dhananjay, et al.. (2022). Genetic evidence of aberrant striatal synaptic maturation and secretory pathway alteration in a dystonia mouse model. PubMed. 1. 3 indexed citations

Yellajoshyula, Dhananjay, Samuel S. Pappas, Biswa Choudhury, et al.. (2021). THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes. Proceedings of the National Academy of Sciences. 118(31). 11 indexed citations

Yellajoshyula, Dhananjay, et al.. (2021). A pathogenic DYT-THAP1 dystonia mutation causes hypomyelination and loss of YY1 binding. Human Molecular Genetics. 31(7). 1096–1104. 11 indexed citations

Li, Jay, et al.. (2021). CNS critical periods: implications for dystonia and other neurodevelopmental disorders. JCI Insight. 6(4). 18 indexed citations

Albin, Roger L., Martijn L.T.M. Müller, Nicolaas I. Bohnen, et al.. (2021). α4β2 ^* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders. Annals of Neurology. 90(1). 130–142. 15 indexed citations

Li, Jay, et al.. (2021). TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia. Journal of Clinical Investigation. 131(6). 19 indexed citations

Albin, Roger L., Nicolaas I. Bohnen, Martijn L.T.M. Müller, et al.. (2018). Regional vesicular acetylcholine transporter distribution in human brain: A [¹⁸F]fluoroethoxybenzovesamicol positron emission tomography study. The Journal of Comparative Neurology. 526(17). 2884–2897. 50 indexed citations

Yellajoshyula, Dhananjay, Chun-Chi Liang, Samuel S. Pappas, et al.. (2017). The DYT6 Dystonia Protein THAP1 Regulates Myelination within the Oligodendrocyte Lineage. Developmental Cell. 42(1). 52–67.e4. 39 indexed citations

10.

Dauer, William T., et al.. (2014). Nuclear envelope breakdown induced by herpes simplex virus type 1 involves the activity of viral fusion proteins. Virology. 460-461. 128–137. 17 indexed citations

11.

Shin, Ji‐Yeon, Iván Méndez-López, Yuexia Wang, et al.. (2013). Lamina-Associated Polypeptide-1 Interacts with the Muscular Dystrophy Protein Emerin and Is Essential for Skeletal Muscle Maintenance. Developmental Cell. 26(6). 591–603. 74 indexed citations

12.

Kett, Lauren R. & William T. Dauer. (2012). Leucine-Rich Repeat Kinase 2 for Beginners: Six Key Questions. Cold Spring Harbor Perspectives in Medicine. 2(3). a009407–a009407. 32 indexed citations

13.

Brown, Timothy, et al.. (2011). Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Therapy. 18(7). 666–673. 83 indexed citations

14.

Dauer, William T. & Howard J. Worman. (2009). The Nuclear Envelope as a Signaling Node in Development and Disease. Developmental Cell. 17(5). 626–638. 182 indexed citations

15.

Martínez‐Vicente, Marta, Zsolt Tallóczy, Susmita Kaushik, et al.. (2008). Dopamine-modified α-synuclein blocks chaperone-mediated autophagy. Journal of Clinical Investigation. 118(2). 777–88. 516 indexed citations breakdown →

16.

Weisstaub, Noelia, Ming‐Ming Zhou, Alena Lira, et al.. (2006). Cortical 5-HT _2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice. Science. 313(5786). 536–540. 328 indexed citations

17.

Goodchild, Rose E. & William T. Dauer. (2005). The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. The Journal of Cell Biology. 168(6). 855–862. 177 indexed citations

18.

Goodchild, Rose E. & William T. Dauer. (2004). Mislocalization to the nuclear envelope: An effect of the dystonia-causing torsinA mutation. Proceedings of the National Academy of Sciences. 101(3). 847–852. 208 indexed citations

19.

Dauer, William T., Nikolai Kholodilov, Miquel Vila, et al.. (2002). Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP. Proceedings of the National Academy of Sciences. 99(22). 14524–14529. 457 indexed citations

20.

Lewis, Susan E., Mahendra S. Rao, Aviva J. Symes, et al.. (1994). Coordinate Regulation of Choline Acetyltransferase, Tyrosine Hydroxylase, and Neuropeptide mRNAs by Ciliary Neurotrophic Factor and Leukemia Inhibitory Factor in Cultured Sympathetic Neurons. Journal of Neurochemistry. 63(2). 429–438. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact